+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tinea Pedis Treatment Market - Global Forecast to 2030- Product Image
Tinea Pedis Treatment Market - Global Forecast to 2030- Product Image
Sale

Tinea Pedis Treatment Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5888825
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Tinea Pedis Treatment Market grew from USD 1.57 billion in 2024 to USD 1.68 billion in 2025. It is expected to continue growing at a CAGR of 6.36%, reaching USD 2.28 billion by 2030.

Tinea pedis, commonly known as athlete’s foot, poses a persistent health challenge affecting millions worldwide. Its prevalence among athletes, military personnel and the general population underscores the need for effective treatment options. Over time, the emergence of drug-resistant fungal strains and shifts in patient expectations have driven innovation across both prescription and over-the-counter formulations. Moreover, evolving channels of distribution-from traditional pharmacies to digital platforms-have reshaped how consumers access medication.

This executive summary explores the current landscape of tinea pedis treatment, highlighting key industry developments, regulatory influences and market dynamics. By examining transformative shifts, the impact of recent United States tariff changes and critical segmentation patterns, readers will gain a consolidated view of strategic growth opportunities. Subsequent sections delve into regional variations, competitive forces and actionable recommendations, culminating in a concise call-to-action for stakeholders seeking in-depth intelligence on this dynamic market.

Transformative Shifts Reshaping the Competitive Landscape

Over the past few years, the tinea pedis treatment landscape has undergone significant transformation driven by scientific, regulatory and consumer-driven forces. Advances in topical antifungal chemistry have yielded novel allylamine and azole derivatives with improved skin penetration and reduced treatment durations. Concurrently, pharmaceutical companies have intensified development of once-daily and single-application formulations to enhance patient adherence.

Digital health solutions are also playing an increasingly pivotal role. Telemedicine consultations now enable remote diagnosis and treatment recommendations, while online platforms facilitate direct-to-consumer fulfillment. In parallel, the emergence of personalized medicine approaches is redefining product positioning, with lifestyle profiling guiding the selection between sprays for athletes and absorbent powders for field workers.

Sustainability considerations have further influenced packaging and ingredient sourcing, prompting manufacturers to adopt eco-friendly materials and traceable supply chains. These cumulative shifts underscore a more patient-centric paradigm, emphasizing convenience, efficacy and environmental responsibility.

Cumulative Impact of United States Tariffs in 2025

In early 2025, the United States enacted a series of additional tariffs on imported active ingredients and finished tinea pedis treatments, notably affecting key inputs such as antifungal powders, creams and oral tablet excipients. As a result, many manufacturers faced increased cost pressures, triggering a reevaluation of sourcing strategies and prompting nearshoring initiatives to mitigate tariff exposure.

These duties have also prompted tighter collaboration between formulators and suppliers to secure long-term contracts at stable prices. Some organizations have responded by reformulating products to incorporate domestically sourced ingredients, while others have expanded backward integration into manufacturing to preserve margin integrity. Moreover, industry alliances are advocating for tariff exemptions on essential APIs to alleviate the burden on patients, many of whom rely on affordable over-the-counter treatments.

Ultimately, the 2025 tariff revisions have accelerated strategic realignments across the supply chain, encouraging greater resilience through diversified procurement, stronger supplier partnerships and selective domestic manufacturing investments.

Key Segmentation Insights and Market Dynamics

Treatment type underscores a fundamental market division between oral medications and topical treatments. Within the oral segment, capsules and tablets dominate, with antifungal-specific tablet formulations capturing particular attention due to their systemic efficacy. Topical treatments span creams, powders and sprays, each sub-category tailored to distinct usage scenarios: over-the-counter creams address mild to moderate infections, while prescription strengths target more persistent cases. Absorbent powders cater to patients seeking moisture control, whereas antifungal powders deliver direct mycotic inhibition. Aerosol and pump sprays offer rapid application, favored by active individuals for their convenience.

Patient demographics further refine market strategies. Age group distinctions reveal higher demand among adults and the elderly, while specialized pediatric formulations address children’s unique needs. Gender and lifestyle factors drive product design; for instance, formulations for athletes incorporate sweat-resistant technologies, whereas offerings for desk-bound workers focus on discreet application. Occupation-based preferences emerge as well, with field workers prioritizing long-lasting protection in challenging environments.

Distribution channels continue to evolve, bridging offline pharmacies, including both hospital and retail outlets, with company-owned websites and large-scale e-commerce platforms. This hybrid model enhances accessibility, allowing clinics and hospitals to stock prescription-only products, while individual patients conveniently reorder maintenance treatments online.

Active ingredient selection remains critical, with allylamines, azoles and pyridones each presenting distinct pharmacological profiles and safety margins. Meanwhile, end-users vary from institutional clinics that require bulk procurement solutions to individual patients seeking single-dose or multi-application packs. Formulation matrices-whether bindable bases for solid dosage forms or oil/water emulsions for topical efficacy-affect both therapeutic performance and patient satisfaction. Lastly, application frequency divides the market between formulations designed for multiple daily uses and those engineered for single-application convenience, the latter becoming increasingly popular among time-constrained consumers.

Regional Variations and Growth Opportunities

Regional dynamics reveal that the Americas remain a leading market, driven by high healthcare spending and robust insurance coverage that facilitate patient access to both prescription and over-the-counter treatments. In contrast, Europe, the Middle East & Africa exhibit diverse regulatory landscapes, where stringent EU regulations ensure high quality but demand extensive clinical validation for new formulations, while emerging EMEA markets are characterized by rapid uptake of cost-effective generics.

Asia-Pacific markets encompass a broad spectrum of maturity. Advanced economies such as Japan and Australia support premium branded products and sophisticated delivery mechanisms, whereas Southeast Asian and South Asian countries demonstrate strong demand for affordable, locally manufactured powders and creams. Regulatory harmonization efforts within ASEAN and initiatives to improve healthcare infrastructure continue to expand patient access to modern antifungal therapies.

Competitive Dynamics and Leading Players

A competitive field features global pharmaceutical giants and specialized biotech firms. Abbott Laboratories leverages robust distribution networks to sustain over-the-counter sales, while Aetna Inc influences formulary decisions through payer agreements. Alva-Amco Pharmacal Companies and Creative Biolabs focus on niche formulation technologies, and Amneal Pharmaceuticals and Cipla Ltd. emphasize affordable generic offerings. Aurobindo Pharma and Dr. Reddy’s Laboratories invest in research around novel allylamine derivatives, as Bausch Health and Bayer AG explore aerosol spray innovations for rapid symptom relief.

Blueberry Therapeutics and ProFoot, Inc. differentiate through patent-protected bindable bases and pump delivery systems. Enzon Pharmaceuticals applies advanced nanocarrier technology to enhance skin penetration, whereas GlaxoSmithKline and Merck & Co. concentrate on prescription strengths backed by extensive clinical data. Glenmark and Mylan N.V. engage in strategic licensing for regional expansions, while Novartis AG and Perrigo Company PLC integrate sustainable packaging solutions. Sebela Pharmaceuticals and Sun Pharmaceutical Industries focus on prescription creams, while Steris Healthcare provides sterilization and manufacturing support. Taisho Pharmaceutical and Vibcare Pharma target Asia-Pacific distribution, completing a mosaic of innovation, scale and specialization across the tinea pedis treatment market.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize innovation in formulation and delivery. Investing in extended-release topical technologies or single-application systems can enhance adherence and differentiate portfolios. Additionally, forging partnerships with telehealth providers will streamline remote diagnosis and prescription fulfillment, capturing digital-savvy demographics.

Given recent tariff shifts, diversification of supply chains is paramount. Establishing regional manufacturing hubs in North America and Asia-Pacific can mitigate import duties and logistical risks. Concurrently, engaging with regulatory bodies across EMEA to secure fast-track reviews and tariff exemptions on critical APIs will reduce time-to-market and preserve margins.

Leveraging patient data analytics can refine segmentation strategies, tailoring marketing for athletes, field workers and the elderly. Finally, sustainability must remain core to product development. Adopting recyclable packaging and ethically sourced ingredients not only meets regulatory expectations but also resonates with environmentally conscious consumers.

Conclusion and Strategic Outlook

A comprehensive approach to tinea pedis treatment requires balancing innovation, accessibility and operational resilience. As digital channels expand, manufacturers must integrate omnichannel strategies, ensuring seamless transitions between in-clinic prescription and at-home fulfillment. Strategic alliances with e-commerce platforms and hospital pharmacies will maximize reach while preserving brand integrity.

Efforts to reformulate existing therapies for single-dose efficacy or extended-release performance can command premium pricing and improve patient outcomes. At the same time, nearshoring and regional production partnerships will safeguard against future tariff disruptions and strengthen supply chain transparency.

Ultimately, companies that embrace data-driven segmentation, invest in patient-friendly delivery systems and proactively engage with policymakers to shape favorable tariff and regulatory frameworks will secure sustainable competitive advantage in the evolving tinea pedis market.

Market Segmentation & Coverage

This research report categorizes the Tinea Pedis Treatment Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Oral Medications
    • Capsules
    • Tablets
      • Antifungal
  • Topical Treatments
    • Creams
      • Over-The-Counter
      • Prescription
    • Powders
      • Absorbent Powders
      • Antifungal Powders
    • Sprays
      • Aerosol
      • Pump
  • Age Group
    • Adults
    • Children
    • Elderly
  • Gender
    • Female
    • Male
  • Lifestyle
    • Athletes
    • Non-Athletes
  • Occupation
    • Desk Job
    • Field Workers
  • Offline Pharmacies
    • Hospital Pharmacies
    • Retail Pharmacies
  • Online Platforms
    • Company-Owned Websites
    • E-Commerce Platforms
  • Allylamines
  • Azoles
  • Pyridones
  • Clinics & Hospitals
  • Individual Patients
  • Bindable Bases
  • Oil/Water Emulsions
  • Multiple Applications
  • Single Application

This research report categorizes the Tinea Pedis Treatment Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Tinea Pedis Treatment Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • Aetna Inc
  • Alva-Amco Pharmacal Companies, Inc
  • Amneal Pharmaceuticals Inc.
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd.
  • Cipla Ltd.
  • Creative Biolabs
  • Dr. Reddy's Laboratories Ltd.
  • Enzon Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Perrigo Company PLC
  • ProFoot, Inc.
  • Sebela Pharmaceuticals Holdings Inc.
  • Steris Healthcare PVT Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • Vibcare Pharma Pvt. Ltd.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Tinea Pedis Treatment Market, by Treatment Type
8.1. Introduction
8.2. Oral Medications
8.2.1. Capsules
8.2.2. Tablets
8.2.2.1. Antifungal
8.3. Topical Treatments
8.3.1. Creams
8.3.1.1. Over-The-Counter
8.3.1.2. Prescription
8.3.2. Powders
8.3.2.1. Absorbent Powders
8.3.2.2. Antifungal Powders
8.3.3. Sprays
8.3.3.1. Aerosol
8.3.3.2. Pump
9. Tinea Pedis Treatment Market, by Patient Demographics
9.1. Introduction
9.2. Age Group
9.2.1. Adults
9.2.2. Children
9.2.3. Elderly
9.3. Gender
9.3.1. Female
9.3.2. Male
9.4. Lifestyle
9.4.1. Athletes
9.4.2. Non-Athletes
9.5. Occupation
9.5.1. Desk Job
9.5.2. Field Workers
10. Tinea Pedis Treatment Market, by Distribution Channel
10.1. Introduction
10.2. Offline Pharmacies
10.2.1. Hospital Pharmacies
10.2.2. Retail Pharmacies
10.3. Online Platforms
10.3.1. Company-Owned Websites
10.3.2. E-Commerce Platforms
11. Tinea Pedis Treatment Market, by Active Ingredient
11.1. Introduction
11.2. Allylamines
11.3. Azoles
11.4. Pyridones
12. Tinea Pedis Treatment Market, by End-User
12.1. Introduction
12.2. Clinics & Hospitals
12.3. Individual Patients
13. Tinea Pedis Treatment Market, by Formulation Type
13.1. Introduction
13.2. Bindable Bases
13.3. Oil/Water Emulsions
14. Tinea Pedis Treatment Market, by Application Frequency
14.1. Introduction
14.2. Multiple Applications
14.3. Single Application
15. Americas Tinea Pedis Treatment Market
15.1. Introduction
15.2. Argentina
15.3. Brazil
15.4. Canada
15.5. Mexico
15.6. United States
16. Asia-Pacific Tinea Pedis Treatment Market
16.1. Introduction
16.2. Australia
16.3. China
16.4. India
16.5. Indonesia
16.6. Japan
16.7. Malaysia
16.8. Philippines
16.9. Singapore
16.10. South Korea
16.11. Taiwan
16.12. Thailand
16.13. Vietnam
17. Europe, Middle East & Africa Tinea Pedis Treatment Market
17.1. Introduction
17.2. Denmark
17.3. Egypt
17.4. Finland
17.5. France
17.6. Germany
17.7. Israel
17.8. Italy
17.9. Netherlands
17.10. Nigeria
17.11. Norway
17.12. Poland
17.13. Qatar
17.14. Russia
17.15. Saudi Arabia
17.16. South Africa
17.17. Spain
17.18. Sweden
17.19. Switzerland
17.20. Turkey
17.21. United Arab Emirates
17.22. United Kingdom
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Abbott Laboratories
18.3.2. Aetna Inc
18.3.3. Alva-Amco Pharmacal Companies, Inc
18.3.4. Amneal Pharmaceuticals Inc.
18.3.5. Aurobindo Pharma Limited
18.3.6. Bausch Health Companies Inc.
18.3.7. Bayer AG
18.3.8. Blueberry Therapeutics Ltd.
18.3.9. Cipla Ltd.
18.3.10. Creative Biolabs
18.3.11. Dr. Reddy's Laboratories Ltd.
18.3.12. Enzon Pharmaceuticals, Inc.
18.3.13. GlaxoSmithKline PLC
18.3.14. Glenmark Pharmaceuticals Limited
18.3.15. Merck & Co., Inc.
18.3.16. Mylan N.V.
18.3.17. Novartis AG
18.3.18. Perrigo Company PLC
18.3.19. ProFoot, Inc.
18.3.20. Sebela Pharmaceuticals Holdings Inc.
18.3.21. Steris Healthcare PVT Ltd
18.3.22. Sun Pharmaceutical Industries Ltd.
18.3.23. Taisho Pharmaceutical Co., Ltd.
18.3.24. Vibcare Pharma Pvt. Ltd.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. TINEA PEDIS TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. TINEA PEDIS TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. TINEA PEDIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2024 VS 2030 (%)
FIGURE 20. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 24. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 28. EUROPE, MIDDLE EAST & AFRICA TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 29. TINEA PEDIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 30. TINEA PEDIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TINEA PEDIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ANTIFUNGAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OVER-THE-COUNTER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PRESCRIPTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ABSORBENT POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ANTIFUNGAL POWDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY AEROSOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PUMP, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CHILDREN, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ELDERLY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY FEMALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY MALE, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ATHLETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY NON-ATHLETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY DESK JOB, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY FIELD WORKERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY COMPANY-OWNED WEBSITES, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY ALLYLAMINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY AZOLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY PYRIDONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY CLINICS & HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY INDIVIDUAL PATIENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY BINDABLE BASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY OIL/WATER EMULSIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY MULTIPLE APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL TINEA PEDIS TREATMENT MARKET SIZE, BY SINGLE APPLICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 106. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 108. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 125. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 126. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 127. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 128. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 129. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 130. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 131. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 132. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 133. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 134. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 135. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 136. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 137. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 139. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 140. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 141. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 143. CANADA TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 144. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 145. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 146. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 147. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 148. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 150. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 151. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 152. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 153. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 154. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 155. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 156. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 157. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 158. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 160. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 162. MEXICO TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 163. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 164. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 165. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES TINEA PEDIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 183. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 184. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 185. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC TINEA PEDIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 203. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 204. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 205. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 222. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 223. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 224. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 225. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 226. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 227. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 228. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 229. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 230. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 231. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 232. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 233. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 234. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 236. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 237. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 238. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 240. CHINA TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 241. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 242. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 243. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 244. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 245. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 246. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 247. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 248. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 249. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 250. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 251. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 252. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 253. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 255. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 256. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 257. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 258. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 259. INDIA TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 260. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 261. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 262. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 270. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 279. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 280. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 281. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 282. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 283. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 284. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 285. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 286. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 287. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 288. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 289. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 290. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 291. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 292. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 293. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 294. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 295. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 296. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 297. JAPAN TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 298. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 299. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 300. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 308. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 309. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 310. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 311. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 312. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 313. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 314. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 315. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 316. MALAYSIA TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 317. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 318. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 319. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY TABLETS, 2018-2030 (USD MILLION)
TABLE 320. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY TOPICAL TREATMENTS, 2018-2030 (USD MILLION)
TABLE 321. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY CREAMS, 2018-2030 (USD MILLION)
TABLE 322. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY POWDERS, 2018-2030 (USD MILLION)
TABLE 323. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY SPRAYS, 2018-2030 (USD MILLION)
TABLE 324. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY PATIENT DEMOGRAPHICS, 2018-2030 (USD MILLION)
TABLE 325. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY AGE GROUP, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY GENDER, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY LIFESTYLE, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY OCCUPATION, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY OFFLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY ONLINE PLATFORMS, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES TINEA PEDIS TREATMENT MARKET SIZE, BY APPLICATION FREQUENCY, 2018-2030 (USD MILLION)
TABLE 336. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 337. SINGAPORE TINEA PEDIS TREATMENT MARKET SIZE, BY ORAL MEDICATIONS, 2018-2030 (USD MILLION)
TABLE 338. SINGAPORE TINEA PEDIS TREATMENT M

Companies Mentioned

  • Abbott Laboratories
  • Aetna Inc
  • Alva-Amco Pharmacal Companies, Inc
  • Amneal Pharmaceuticals Inc.
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd.
  • Cipla Ltd.
  • Creative Biolabs
  • Dr. Reddy's Laboratories Ltd.
  • Enzon Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Glenmark Pharmaceuticals Limited
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Perrigo Company PLC
  • ProFoot, Inc.
  • Sebela Pharmaceuticals Holdings Inc.
  • Steris Healthcare PVT Ltd
  • Sun Pharmaceutical Industries Ltd.
  • Taisho Pharmaceutical Co., Ltd.
  • Vibcare Pharma Pvt. Ltd.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Tinea Pedis Treatment Market Report 2025 - Product Image

Tinea Pedis Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Tinea Pedis (Athlete's Foot) Treatment - Global Strategic Business Report - Product Image

Tinea Pedis (Athlete's Foot) Treatment - Global Strategic Business Report

  • Report
  • 284 Pages
  • Global
From
Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2025 - Product Image

Athlete's Foot (Tinea Pedis) - Pipeline Insight, 2025

  • Clinical Trials
  • 60 Pages
  • Global
From
Tinea Pedis - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Tinea Pedis - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
Treatment of Skin Disease. Comprehensive Therapeutic Strategies. Edition No. 6 - Product Image

Treatment of Skin Disease. Comprehensive Therapeutic Strategies. Edition No. 6

  • Book

About the Tinea Pedis Drug Market

Tinea Pedis, commonly known as athlete's foot, is a fungal infection of the skin that affects the feet. It is caused by a variety of fungi, including Trichophyton, Epidermophyton, and Microsporum. Treatment for tinea pedis typically involves the use of antifungal drugs, such as terbinafine, itraconazole, and clotrimazole. These drugs are available in both topical and oral forms, and are used to treat the infection and prevent its recurrence. The tinea pedis drug market is a segment of the infectious diseases drugs market. It is composed of a variety of antifungal drugs used to treat tinea pedis. These drugs are available in both prescription and over-the-counter forms, and are used to treat the infection and prevent its recurrence. Some companies in the tinea pedis drug market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Bayer. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.